Singular Genomics Systems, Inc. (OMIC)
NASDAQ: OMIC · Real-Time Price · USD
22.41
+0.10 (0.44%)
Nov 5, 2024, 11:16 AM EST - Market open

Singular Genomics Systems Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Revenue
2.722.910.77---
Revenue Growth (YoY)
27.66%280.52%----
Cost of Revenue
3.843.470.79---
Gross Profit
-1.12-0.56-0.02---
Selling, General & Admin
52.0252.5847.2628.626.292.29
Research & Development
44.7347.7646.232.6621.2510.48
Operating Expenses
96.75100.3493.4661.2827.5312.77
Operating Income
-97.87-100.9-93.49-61.28-27.53-12.77
Interest Expense
-1.14-1.1-0.76-0.85-0.72-0.02
Interest & Investment Income
8.739.083.370.730.460.41
Other Non Operating Income (Expenses)
----2.18-0.160.05
EBT Excluding Unusual Items
-90.29-92.92-90.88-63.57-27.95-12.33
Gain (Loss) on Sale of Investments
-----0.01
Asset Writedown
--1.9----
Other Unusual Items
----35.2--
Pretax Income
-91.89-94.82-90.88-98.77-27.95-12.32
Net Income
-91.89-94.82-90.88-98.77-27.95-12.32
Net Income to Common
-91.89-94.82-90.88-98.77-27.95-12.32
Shares Outstanding (Basic)
222200
Shares Outstanding (Diluted)
222200
Shares Change (YoY)
2.73%2.32%51.30%344.62%22.69%-
EPS (Basic)
-37.37-39.08-38.32-63.01-79.27-42.89
EPS (Diluted)
-37.37-39.08-38.40-63.01-79.27-42.89
Free Cash Flow
-77.98-74.62-93.12-56.57-26.25-12.2
Free Cash Flow Per Share
-31.71-30.75-39.26-36.09-74.47-42.46
Gross Margin
-41.06%-19.17%-3.14%---
Operating Margin
-3594.27%-3466.20%-12220.52%---
Profit Margin
-3374.48%-3257.30%-11879.61%---
Free Cash Flow Margin
-2863.90%-2563.28%-12172.03%---
EBITDA
-93.94-97.39-91.06-60.15-26.9-12.42
D&A For EBITDA
3.933.512.431.130.640.35
EBIT
-97.87-100.9-93.49-61.28-27.53-12.77
Source: S&P Capital IQ. Standard template. Financial Sources.